Blood Cell-Bound C4d as a Marker of Complement Activation in Patients With the Antiphospholipid Syndrome

Antiphospholipid syndrome (APS) is a chronic and disabling condition characterized by recurrent thrombosis and miscarriages mediated by antibodies against phospholipid-binding proteins (aPL), such as beta(2)glycoprotein I (β(2)GPI). Complement is involved in APS animal models and complement deposits...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Front Immunol
Egile Nagusiak: Lonati, Paola Adele, Scavone, Mariangela, Gerosa, Maria, Borghi, Maria Orietta, Pregnolato, Francesca, Curreli, Daniele, Podda, Gianmarco, Femia, Eti Alessandra, Barcellini, Wilma, Cattaneo, Marco, Tedesco, Francesco, Meroni, Pier Luigi
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Frontiers Media S.A. 2019
Gaiak:
Immunology
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC6474283/
https://ncbi.nlm.nih.gov/pubmed/31031764
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fimmu.2019.00773
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak